Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma

Conclusions: Our findings highlight MXD3 as a promising prognostic biomarker for LUSC, with high MXD3 expression predicting poorer survival outcomes. MXD3 expression level, along with lymph node involvement and methylation status, could serve as independent prognostic indicators for risk stratificat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingzhi Cao, Ning Zhang, Tangbing Chen, Hong Jiang
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/ijog/7355595
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152985276973056
author Mingzhi Cao
Ning Zhang
Tangbing Chen
Hong Jiang
author_facet Mingzhi Cao
Ning Zhang
Tangbing Chen
Hong Jiang
author_sort Mingzhi Cao
collection DOAJ
description Conclusions: Our findings highlight MXD3 as a promising prognostic biomarker for LUSC, with high MXD3 expression predicting poorer survival outcomes. MXD3 expression level, along with lymph node involvement and methylation status, could serve as independent prognostic indicators for risk stratification and treatment decision-making in LUSC patients. Further research is warranted to elucidate the underlying mechanisms of MXD3-mediated tumorigenesis and its potential as a therapeutic target in LUSC management.
format Article
id doaj-art-8639507a4d164518808a528d4a2c059a
institution OA Journals
issn 2314-4378
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-8639507a4d164518808a528d4a2c059a2025-08-20T02:25:50ZengWileyInternational Journal of Genomics2314-43782025-01-01202510.1155/ijog/7355595Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell CarcinomaMingzhi Cao0Ning Zhang1Tangbing Chen2Hong Jiang3Department of Thoracic SurgeryDepartment of Thoracic SurgeryDepartment of Thoracic SurgeryDepartment of Thoracic SurgeryConclusions: Our findings highlight MXD3 as a promising prognostic biomarker for LUSC, with high MXD3 expression predicting poorer survival outcomes. MXD3 expression level, along with lymph node involvement and methylation status, could serve as independent prognostic indicators for risk stratification and treatment decision-making in LUSC patients. Further research is warranted to elucidate the underlying mechanisms of MXD3-mediated tumorigenesis and its potential as a therapeutic target in LUSC management.http://dx.doi.org/10.1155/ijog/7355595
spellingShingle Mingzhi Cao
Ning Zhang
Tangbing Chen
Hong Jiang
Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
International Journal of Genomics
title Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
title_full Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
title_fullStr Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
title_full_unstemmed Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
title_short Assessment of MXD3 Expression as a Predictor of Survival in Lung Squamous Cell Carcinoma
title_sort assessment of mxd3 expression as a predictor of survival in lung squamous cell carcinoma
url http://dx.doi.org/10.1155/ijog/7355595
work_keys_str_mv AT mingzhicao assessmentofmxd3expressionasapredictorofsurvivalinlungsquamouscellcarcinoma
AT ningzhang assessmentofmxd3expressionasapredictorofsurvivalinlungsquamouscellcarcinoma
AT tangbingchen assessmentofmxd3expressionasapredictorofsurvivalinlungsquamouscellcarcinoma
AT hongjiang assessmentofmxd3expressionasapredictorofsurvivalinlungsquamouscellcarcinoma